Click to go to DrugInjuryLaw Home


Legal information and news about prescription drug side effects
NuvaRing Case Evaluation Ortho Evra Case Evaluation Fosamax Case Evaluation Avandia Case EvaluationKetek Case Evaluation Zelnorm Case Evaluation Meridia Case Evaluation
Vytorin Case EvaluationZetia Case Evaluation Yasmin Case Evaluation Ocella Case EvaluationYAZ Case Evaluation Levaquin Case Evaluation Byetta Case Evaluation


Free Case Evaluation

Public Citizen Petitions FDA To Ban Abbott Diet Drug Meridia In December 2009

This Is Second Request For Meridia Recall By The Consumer Group; Its First Petition Was Filed In 2002, Denied In 2005

In early December 2009 Public Citizen filed its "Petition to Ban Sibutramine (Meridia)" with the FDA, in which this consumer group requested that Abbott Laboratories Inc's weight-loss drug Meridia be banned immediately because of heart-related side effect risks.

In its December 2009 Petition, Public Citizen said early results from a large international study called SCOUT added to the consumer group's previous safety concerns -- which were first expressed in Public Citizen's March 2002 FDA Petition regarding Meridia -- that Meridia could cause heart attacks, strokes, and other serious cardiac problems: "The fact that [Meridia] actually increased the number and percentage of cardiovascular events [in the SCOUT study] ... should mandate its immediate removal from the market."

Back in November 2009 the FDA issued an "Early Communication about an Ongoing Safety Review of Meridia (sibutramine hydrochloride)" to let the public know about a possible increased risk for adverse cardiovascular events associated with the obesity drug Meridia.

Returning to the December 2009 Meridia Petition submitted to the FDA, Public Citizen said 84 heart-related deaths had been reported to the FDA in patients who took Meridia; 30 of the people who died were age 50 or younger, and 11 were age 30 or younger.

As mentioned above, the FDA rejected an earlier Petition to ban Meridia from Public Citizen. In its 2005 decision the FDA said that Meridia's benefits outweighed its risks when used appropriately, adding that it was not possible to conclude that Meridia had caused the reported heart-related side effects.

However, the FDA stated in its 2005 denial that an assessment of Meridia's heart risks could best be made though a large trial, such as the SCOUT study -- a point which Public Citizen emphasized in its most recent "Petition to Ban Sibutramine (Meridia)".

Go to Free Meridia Case Evaluation form >>

Read more on our Meridia Information Page >>


  • US FDA advises that you should not stop taking any prescription medication before talking to your doctor.
  • Reports of serious drug side effects should be made to the US FDA MedWatch program.
  • The prescription drug names are registered trademarks of the respective drug companies.
  • DrugInjuryLaw.com is not affiliated with any of the drug companies, nor US FDA.
Law Offices of Thomas J. Lamb, P.A.
Lumina Station Suite 225
1908 Eastwood Road
Wilmington, NC 28403
Tel: (910) 256-2971   Fax: (910) 256-2972
Toll Free: (800) 426-9535
email: ThomasJLamb@DrugInjuryLaw.com

Disclaimer